반응식
Cl[C:2]1[CH:7]=[C:6]([F:8])[CH:5]=[CH:4][C:3]=1[CH2:9][NH:10][C:11](=[O:20])[C@@H:12]1[CH2:16][CH2:15][C:14](=[O:17])[N:13]1[CH2:18]C.CN1C(=O)CC[C@H]1C(O)=O.C(N1C(=O)CC[C@H]1C(O)=O)C.FC1C=CC(CN)=C([C:51]([F:54])([F:53])[F:52])C=1.ClC1C=C(F)C=CC=1CN>>[F:8][C:6]1[CH:5]=[CH:4][C:3]([CH2:9][NH:10][C:11](=[O:20])[C@@H:12]2[CH2:16][CH2:15][C:14](=[O:17])[N:13]2[CH3:18])=[C:2]([C:51]([F:54])([F:53])[F:52])[CH:7]=1참가 물질
6
반응물 5
생성물 1
실험 절차
N-{[4-fluoro-2-(trifluoromethyl)phenyl]methyl}-1-methyl-5-oxoprolinamide was prepared in a manner analogous to that described above for the synthesis of N-[(2-chloro-4-fluorophenyl)methyl]-1-ethyl-5-oxoprolinamide (Example 70) but 1-methyl-5-oxoproline (prepared as describe below) was substituted for 1-ethyl-5-oxoproline and {[4-fluoro-2-(trifluoromethyl)phenyl]methyl}amine was substituted for 2-chloro-4-fluorobenzylamine.
출처 및 근거
- ORD 기록
- ord-c6c8234805c647959e5883507a9420bf
- 출처 데이터셋
- uspto-grants-2011_11
- 특허 번호
- US08048907B2
연결된 노트
불러오는 중…